Pi Therapeutics

Inhibitors for Cancer Treatment

Health Tech & Life Sciences
Non Active, Apr 2023 ceased to operate
Series B Netanya Founded 2015
Total raised
$19.7M
Last: Series B 2019-05
Stage
Series B
Founded
2015
Headcount
6
HQ
Netanya
Sector
Health Tech & Life Sciences

About

Pi Therapeutics is a preclinical-stage pharmaceutical company dedicated to the development of protein degradation modulators for the treatment of cancer. The companys lead drug modulates pathways related to proteostasis, offering a unique approach to the preferential targeting of cancer cells. Preclinical data to date have demonstrated a compelling safety and efficacy profile which is differentiated from approved protein degradation inhibitors. The company targets hematologic as well as solid tumor indications and expects to initiate clinical studies next year. Pi Therapeutics was founded based on technology in-licensed from Johns Hopkins University.

Funding history · 2 rounds · $19.7M total

2019-05
Series B $19.7M
2017-01
Seed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Pi Therapeutics?
Pi Therapeutics is a preclinical-stage pharmaceutical company focused on developing protein degradation modulators for cancer treatment.
When was Pi Therapeutics founded?
Pi Therapeutics was founded in March 2015.
What is the current operational status of Pi Therapeutics?
Pi Therapeutics is currently inactive, having ceased operations in April 2023.
Where is Pi Therapeutics headquartered?
Pi Therapeutics is headquartered in Netanya, Israel.
What was the total amount of funding raised by Pi Therapeutics?
Pi Therapeutics raised a total of $19,700,000 in funding. For a full financing history, please refer to startupim.
When did Pi Therapeutics complete its Series B financing round?
Pi Therapeutics completed its Series B financing round in May 2019, with Pontifax as a lead investor.
From which institution did Pi Therapeutics in-license its foundational technology?
Pi Therapeutics was founded based on technology in-licensed from Johns Hopkins University.
How many employees did Pi Therapeutics have?
Pi Therapeutics had between 1 and 10 employees, with an exact count of 6.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

drug-discoverybiopharmaceuticalpharma-companiescancer